Partnerships between pharma and healthtech have nice potential—however delivering on these partnerships requires overcoming challenges. Expectation and communications can typically make efficient collaboration tough. Hear as Ameya Phadke, affected person non-pharma options chief at Chiesi Group, Dennis Hermann, Head of Europe at Kaia Well being and Dan Weinstein, affiliate principal digital medication observe lead at ZS, talk about how these partnerships can work efficiently and what broader developments they see relating to those partnerships.
You’ll study extra about:
- Key issues for coming into, sustaining and managing partnerships from each pharma and healthtech corporations’ factors of view
- What works nicely—and what doesn’t—in these partnerships, and how one can collaborate efficiently
- The way forward for pharma-healthtech collaborations
